EEG-TMS for Postoperative Delirium After Cardiac Surgery
NCT: NCT07537725 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, single-center, randomized, double-blind, sham-controlled trial evaluating the safety and efficacy of transcranial magnetic stimulation (TMS) for the treatment of postoperative delirium in patients undergoing cardiac surgery with extracorporeal circulation. Eligible patients aged 50 years or older who develop delirium after surgery, as assessed by the CAM-ICU, will be randomized to receive either active TMS or sham stimulation. The intervention consists of three daily cycles of intermittent and continuous theta burst stimulation over five days. The primary outcome is the duration of delirium within the five-day intervention period. Secondary outcomes include delirium severity, time to successful discharge, and survival at 30 and 90 days. A total of 144 participants will be enrolled.
Frequently Asked Questions
What is EEG-TMS for Postoperative Delirium After Cardiac Surgery?
EEG-TMS for Postoperative Delirium After Cardiac Surgery is a clinical trial registered under NCT07537725. Current status: NOT_YET_RECRUITING.
What is the status of NCT07537725?
The current status of NCT07537725 (EEG-TMS for Postoperative Delirium After Cardiac Surgery) is: NOT_YET_RECRUITING.
When did EEG-TMS for Postoperative Delirium After Cardiac Surgery start?
EEG-TMS for Postoperative Delirium After Cardiac Surgery started on 2026-04-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.